Jean-Jacques Mourad: Cohort Study Insights on Aspirin Use in Patients with Horton’s Disease
Jean-Jacques Mourad, Head of Internal Medicine at Franco-British Hospital, shared a post on LinkedIn about a recent article by Maxime Beydon, published in JAMA Network Open, adding:
“When well-constructed and properly analyzed cohort studies provide answers to the gray areas left by randomized trials…
All my sincere congratulations to the French authors of this work, which allows us to weigh a little more clearly the pros and cons of aspirin in patients treated for a Horton’s.”
Title: Low-Dose Aspirin for Cardiovascular Disease Primary Prevention in Patients With Giant Cell Arteritis
Authors: Maxime Beydon, David Hajage, Alexis F. Guédon, Fabrice Carrat, Raphaèle Seror, Florence Tubach
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 23, 2026, 19:17Diego López Santos: Donation after Donation, I Just Reached 100
-
Jul 23, 2026, 19:11Jecko Thachil: Chlorosis May Have Represented Iron Deficiency in the 19th Century
-
Jul 23, 2026, 15:58Mel Snyder: Beyond Sickle Cell Disease to the Future of Pediatric Genetics
-
Jul 23, 2026, 15:43Lorna Knight: The Next Frontier in Sickle Cell Disease Is Access
-
Jul 23, 2026, 15:29Ben Kleinstiver: Overcoming a Major Barrier to Scalable Gene Editing
-
Jul 23, 2026, 15:28Modernizing DIC Diagnosis in Cirrhosis: Building an International Registry for Precision Hemostasi
-
Jul 23, 2026, 14:32Saneha Anjum Shaikh: Why Antibody Screening Must Be Standard Practice in Modern Blood Banking
-
Jul 23, 2026, 14:00Ron Vezina: Canadian Blood Services Issues Urgent Donation Appeal
-
Jul 23, 2026, 13:46Sebastian Szmit: Understanding Troponins in Modern Cardio-Oncology